Cargando…

Low-Protein, Hypocaloric Nutrition with Glutamine versus Full-Feeding in the Acute Phase in ICU Patients with Severe Traumatic Brain Injury

OBJECTIVE: To investigate the 28-day mortality, the length of ICU stay, days in the hospital, days of ventilator use, adverse events, and nosocomial infection events of low-protein, hypocaloric nutrition with glutamine in the first 7 days of the intensive care unit (ICU) patients with severe traumat...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Weichuan, Qian, KeJian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936715/
https://www.ncbi.nlm.nih.gov/pubmed/33688193
http://dx.doi.org/10.2147/NDT.S296296
_version_ 1783661243709521920
author Xiong, Weichuan
Qian, KeJian
author_facet Xiong, Weichuan
Qian, KeJian
author_sort Xiong, Weichuan
collection PubMed
description OBJECTIVE: To investigate the 28-day mortality, the length of ICU stay, days in the hospital, days of ventilator use, adverse events, and nosocomial infection events of low-protein, hypocaloric nutrition with glutamine in the first 7 days of the intensive care unit (ICU) patients with severe traumatic brain injury (STBI). PATIENTS AND METHODS: A total of 53 patients diagnosed with STBI enrolled from the third affiliated hospital of Nanchang University (Nanchang, China), from January 2019 to July 2020, were divided into two groups. We performed a randomized prospective controlled trial. The intervention group (n=27) was nutritional supported (intestinal or parenteral) with a caloric capacity of 20–40% of European Conference on Clinical Nutrition and Metabolism (ESPEN) recommendations; specifically, low-protein intake was 0.5–0.7g/kg per day (containing the amount of alanyl-glutamine), glutamine was 0.3 g/kg per day, and the intervention treatment lasted for 7 days. The control group (n=26) was nutritionally supported with a caloric capacity of 70–100% of ESPEN recommendations, and the protein intake was 1.2–1.7 g/kg per day. The primary endpoint was 28-day mortality. Secondary endpoints were the length of ICU stay, days in the hospital, days of ventilator use, adverse events and nosocomial infection events. RESULTS: There were no differences in baseline characteristics between groups. Survival curve analysis using the Kaplan-Meier method revealed no significant difference in 28-day mortality between the two groups (P=0.31) while adverse events (χ(2)= 5.853, P=0.016), nosocomial infection rate (χ(2) = 4.316, P=0.038), the length of ICU stay (t=−2.617, P=0.012), hospitalization time (t=−2.169, P=0.036), and days of ventilator use (t=−2.144,P=0.037) of patients in the intervention group were significantly lower than those in the control group. CONCLUSION: Low-protein, hypocaloric nutrition with glutamine did not show different outcomes in 28-day mortality compared to full-feeding nutritional support in the ICU patients with STBI. However, low-protein, hypocaloric nutrition with glutamine could provide a lower need for ICU time, hospitalization time, and ventilator time in the ICU patients with STBI.
format Online
Article
Text
id pubmed-7936715
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-79367152021-03-08 Low-Protein, Hypocaloric Nutrition with Glutamine versus Full-Feeding in the Acute Phase in ICU Patients with Severe Traumatic Brain Injury Xiong, Weichuan Qian, KeJian Neuropsychiatr Dis Treat Original Research OBJECTIVE: To investigate the 28-day mortality, the length of ICU stay, days in the hospital, days of ventilator use, adverse events, and nosocomial infection events of low-protein, hypocaloric nutrition with glutamine in the first 7 days of the intensive care unit (ICU) patients with severe traumatic brain injury (STBI). PATIENTS AND METHODS: A total of 53 patients diagnosed with STBI enrolled from the third affiliated hospital of Nanchang University (Nanchang, China), from January 2019 to July 2020, were divided into two groups. We performed a randomized prospective controlled trial. The intervention group (n=27) was nutritional supported (intestinal or parenteral) with a caloric capacity of 20–40% of European Conference on Clinical Nutrition and Metabolism (ESPEN) recommendations; specifically, low-protein intake was 0.5–0.7g/kg per day (containing the amount of alanyl-glutamine), glutamine was 0.3 g/kg per day, and the intervention treatment lasted for 7 days. The control group (n=26) was nutritionally supported with a caloric capacity of 70–100% of ESPEN recommendations, and the protein intake was 1.2–1.7 g/kg per day. The primary endpoint was 28-day mortality. Secondary endpoints were the length of ICU stay, days in the hospital, days of ventilator use, adverse events and nosocomial infection events. RESULTS: There were no differences in baseline characteristics between groups. Survival curve analysis using the Kaplan-Meier method revealed no significant difference in 28-day mortality between the two groups (P=0.31) while adverse events (χ(2)= 5.853, P=0.016), nosocomial infection rate (χ(2) = 4.316, P=0.038), the length of ICU stay (t=−2.617, P=0.012), hospitalization time (t=−2.169, P=0.036), and days of ventilator use (t=−2.144,P=0.037) of patients in the intervention group were significantly lower than those in the control group. CONCLUSION: Low-protein, hypocaloric nutrition with glutamine did not show different outcomes in 28-day mortality compared to full-feeding nutritional support in the ICU patients with STBI. However, low-protein, hypocaloric nutrition with glutamine could provide a lower need for ICU time, hospitalization time, and ventilator time in the ICU patients with STBI. Dove 2021-03-02 /pmc/articles/PMC7936715/ /pubmed/33688193 http://dx.doi.org/10.2147/NDT.S296296 Text en © 2021 Xiong and Qian. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Xiong, Weichuan
Qian, KeJian
Low-Protein, Hypocaloric Nutrition with Glutamine versus Full-Feeding in the Acute Phase in ICU Patients with Severe Traumatic Brain Injury
title Low-Protein, Hypocaloric Nutrition with Glutamine versus Full-Feeding in the Acute Phase in ICU Patients with Severe Traumatic Brain Injury
title_full Low-Protein, Hypocaloric Nutrition with Glutamine versus Full-Feeding in the Acute Phase in ICU Patients with Severe Traumatic Brain Injury
title_fullStr Low-Protein, Hypocaloric Nutrition with Glutamine versus Full-Feeding in the Acute Phase in ICU Patients with Severe Traumatic Brain Injury
title_full_unstemmed Low-Protein, Hypocaloric Nutrition with Glutamine versus Full-Feeding in the Acute Phase in ICU Patients with Severe Traumatic Brain Injury
title_short Low-Protein, Hypocaloric Nutrition with Glutamine versus Full-Feeding in the Acute Phase in ICU Patients with Severe Traumatic Brain Injury
title_sort low-protein, hypocaloric nutrition with glutamine versus full-feeding in the acute phase in icu patients with severe traumatic brain injury
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936715/
https://www.ncbi.nlm.nih.gov/pubmed/33688193
http://dx.doi.org/10.2147/NDT.S296296
work_keys_str_mv AT xiongweichuan lowproteinhypocaloricnutritionwithglutamineversusfullfeedingintheacutephaseinicupatientswithseveretraumaticbraininjury
AT qiankejian lowproteinhypocaloricnutritionwithglutamineversusfullfeedingintheacutephaseinicupatientswithseveretraumaticbraininjury